Current Approaches to Treatment of Ventricular Arrhythmias in Patients with Coronary Artery Disease
Translational Research in Coronary Artery Disease, Page: 141-152
2016
- 1Citations
- 7Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Book Chapter Description
The treatment of ventricular arrhythmias in patients with chronic ischemic cardiomyopathy has evolved over the decades from a primarily medical approach to one dominated by technology and invasive interventions. While the implantable cardioverter-defibrillator has offered extended life to many patients, recurrent ventricular arrhythmias are the cause of significant morbidity still. A complex, multi-modality approach by expert clinicians is necessary for successful management of these patients. Future technological advances will allow for the effective treatment of more patients.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/B9780128023853000127; http://dx.doi.org/10.1016/b978-0-12-802385-3.00012-7; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84967214131&origin=inward; http://linkinghub.elsevier.com/retrieve/pii/B9780128023853000127; http://api.elsevier.com/content/article/PII:B9780128023853000127?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:B9780128023853000127?httpAccept=text/plain; https://linkinghub.elsevier.com/retrieve/pii/B9780128023853000127; https://dx.doi.org/10.1016/b978-0-12-802385-3.00012-7
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know